Early Use of Rosuvastatin (Crestor) in Acute Coronary Syndromes: Targeting Platelet-Leukocyte Interactions.
Phase of Trial: Phase I
Latest Information Update: 03 Apr 2017
At a glance
- Drugs Rosuvastatin (Primary)
- Indications Acute coronary syndromes
- Focus Pharmacodynamics
- 05 Dec 2013 Planned end date changed from 1 May 2013 to 1 Feb 2014 as reported by ClinicalTrials.gov record.
- 05 Dec 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 14 Nov 2012 Planned End Date changed from 1 Sep 2012 to 1 May 2013 as reported by ClinicalTrials.gov.